Myriad Genetics reported $1.39B in Market Capitalization this June of 2022, considering the latest stock price and the number of outstanding shares.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Market Capitalization Change
Accelerate Diagnostics AXDX:US 0.1B 0.25B
Agilent A:US $ 39.71B 8.5B
Becton, Dickinson and BDX:US $ 75.83B 4.21B
Bio Rad Laboratories BIO:US $ 16.98B 5.46B
Biocept BIOC:US $ 0.04B 0.02B
Bruker BRKR:US $ 9.7B 3.03B
Danaher DHR:US $ 209.99B 25.11B
Exact Sciences EXAS:US $ 12.28B 1.24B
Fluidigm FLDM:US $ 0.28B 0.02B
Hologic HOLX:US $ 19.2B 0.04B
Illumina ILMN:US $ 54.89B 4.58B
Johnson & Johnson JNJ:US $ 466.05B 15.69B
Mettler Toledo International MTD:US $ 31.14B 7.87B
Myriad Genetics MYGN:US $ 2.02B 0.19B
Nanostring Technologies NSTG:US $ 1.6B 0.33B
Orasure Technologies OSUR:US $ 0.5B 0.12B
Pacific Biosciences Of California PACB:US $ 2.04B 2.47B
Perkinelmer PKI:US $ 22.01B 3.36B
Quest Diagnostics DGX:US $ 16.12B 5.1B
Quidel QDEL:US $ 4.71B 0.92B
Repligen RGEN:US $ 10.41B 4.24B
Thermo Fisher Scientific TMO:US $ 231.2B 31.72B
Veracyte VCYT:US $ 1.96B 0.96B
Waters WAT:US $ 18.75B 3.99B